Analyst Ratings For Fibrocell Science (NASDAQ:FCSC)
Today, HC Wainwright reiterated its Buy rating on Fibrocell Science (NASDAQ:FCSC) with a price target of $6.00.
Some recent analyst ratings include
- 3/6/2018-HC Wainwright Reiterated Rating of Buy.
- 9/11/2017-Canaccord Genuity Reiterated Rating of Buy.
- 3/7/2017-Rodman & Renshaw initiated coverage with a Buy rating.
- 7/6/2016-Griffin Securities Reiterated Rating of Buy.
- 6/8/2016-Roth Capital Reiterated Rating of Buy.
- 6/8/2016-Wedbush Reiterated Rating of Neutral.
Recent Insider Trading Activity For Fibrocell Science (NASDAQ:FCSC)
Fibrocell Science (NASDAQ:FCSC) has insider ownership of 2.10% and institutional ownership of 48.79%.
- On 12/11/2017 Randal J Kirk, Major Shareholder, bought 2,727,273 with an average share price of $0.77 per share and the total transaction amounting to $2,100,000.21.
- On 12/2/2016 David Pernock, Chairman, bought 50,000 with an average share price of $0.92 per share and the total transaction amounting to $46,000.00.
- On 11/13/2015 David Pernock, CEO, bought 3,000 with an average share price of $5.00 per share and the total transaction amounting to $15,000.00.
- On 8/11/2015 David Pernock, CEO, bought 3,500 with an average share price of $6.54 per share and the total transaction amounting to $22,890.00.
- On 7/27/2015 Randal J Kirk, Major Shareholder, bought 975,987 with an average share price of $5.80 per share and the total transaction amounting to $5,660,724.60.
- On 5/13/2015 David Pernock, CEO, bought 16,600 with an average share price of $4.30 per share and the total transaction amounting to $71,380.00.
- On 12/12/2014 David Pernock, CEO, bought 5,000 with an average share price of $2.52 per share and the total transaction amounting to $12,600.00.
Recent Trading Activity for Fibrocell Science (NASDAQ:FCSC)
Shares of Fibrocell Science closed the previous trading session at with 0.6751000285148621 shares trading hands.